Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial
Titel:
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial
Auteur:
Tannir, Nizar M. Msaouel, Pavlos Ross, Jeremy A. Devine, Catherine E. Chandramohan, Anuradha Gonzalez, Graciela M. Nogueras Wang, Xuemei Wang, Jennifer Corn, Paul G. Lim, Zita D. Pruitt, Lisa Karam, Jose A. Wood, Christopher G. Zurita, Amado J.